Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Schizophrenia

  Free Subscription


04.03.2024

1 Am J Psychiatry
1 Brain Res
1 J Clin Psychiatry
1 J Clin Psychopharmacol
2 J Nerv Ment Dis
1 Neuropsychopharmacology
1 PLoS One
2 Psychiatry Res
2 Psychol Med
11 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Psychiatry

  1. HOU Y, Xia H, He T, Zhang B, et al
    N2 Responses in Youths With Psychosis Risk Syndrome and Their Association With Clinical Outcomes: A Cohort Follow-Up Study Based on the Three-Stimulus Visual Oddball Paradigm.
    Am J Psychiatry. 2024 Feb 29:appiajp20221013. doi: 10.1176/appi.ajp.20221013.
    PubMed         Abstract available


    Brain Res

  2. GAN L, Wang L, Liu H, Wang G, et al
    Based on neural network cascade abnormal texture information dissemination of classification of patients with schizophrenia and depression.
    Brain Res. 2024 Feb 23:148819. doi: 10.1016/j.brainres.2024.148819.
    PubMed         Abstract available


    J Clin Psychiatry

  3. CITROME L, Yagoda S, Bidollari I, Wang M, et al
    Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophre
    J Clin Psychiatry. 2024;85:23m15095.
    PubMed         Abstract available


    J Clin Psychopharmacol

  4. NAGANO M, Susuta Y, Masui H, Watanabe Y, et al
    Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder: Primary Results and Post Hoc Analyses of the J-KINECT Study.
    J Clin Psychopharmacol. 2024;44:107-116.
    PubMed         Abstract available


    J Nerv Ment Dis

  5. EKINCI O, Koyuncu AN
    Assessment of the Readability and Quality of Online Information for Patients and Their Families Regarding Schizophrenia.
    J Nerv Ment Dis. 2024 Jan 25. doi: 10.1097/NMD.0000000000001763.
    PubMed         Abstract available

  6. TSCHOKE S, Knauer Y, Flammer E, Usemann P, et al
    Psychotic Experiences and Daily Functioning in Borderline Personality Disorder and Schizophrenia.
    J Nerv Ment Dis. 2024;212:187-189.
    PubMed         Abstract available


    Neuropsychopharmacology

  7. CABRERA-MENDOZA B, Aydin N, Fries GR, Docherty AR, et al
    Estimating the direct effects of the genetic liabilities to bipolar disorder, schizophrenia, and behavioral traits on suicide attempt using a multivariable Mendelian randomization approach.
    Neuropsychopharmacology. 2024 Feb 23. doi: 10.1038/s41386-024-01833.
    PubMed         Abstract available


    PLoS One

  8. ROSADO D, Intriago B, Loor E, Alcivar F, et al
    Associations between Toxoplasma gondii seropositivity and psychopathological manifestations in schizophrenic patients: A single-center study from Ecuador.
    PLoS One. 2024;19:e0297523.
    PubMed         Abstract available


    Psychiatry Res

  9. KWAK PP, Ibarra C, Hernandez A, Carrasco J, et al
    Differences in metabolic biomarkers in people with schizophrenia who are of Mexican descent compared to non-Hispanic whites.
    Psychiatry Res. 2024;334:115788.
    PubMed         Abstract available

  10. QIN K, Yu Y, Cai H, Li J, et al
    Effectiveness of mindfulness-based intervention in schizophrenia: A meta-analysis of randomized controlled trials.
    Psychiatry Res. 2024;334:115808.
    PubMed         Abstract available


    Psychol Med

  11. ROBINSON N, Ploner A, Leone M, Lichtenstein P, et al
    Environmental risk factors for schizophrenia and bipolar disorder from childhood to diagnosis: a Swedish nested case-control study.
    Psychol Med. 2024 Mar 1:1-10. doi: 10.1017/S0033291724000266.
    PubMed         Abstract available

  12. CORSI-ZUELLI F, Quattrone D, Ragazzi TCC, Loureiro CM, et al
    Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis.
    Psychol Med. 2024 Feb 28:1-13. doi: 10.1017/S0033291724000199.
    PubMed         Abstract available


    Schizophr Res

  13. ISAYEVA U, Manchia M, Collu R, Primavera D, et al
    Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data.
    Schizophr Res. 2024;266:197-204.
    PubMed         Abstract available

  14. SAVILL M, Loewy RL, Niendam TA, Porteus AJ, et al
    The diagnostic accuracy of screening for psychosis spectrum disorders in behavioral health clinics integrated into primary care.
    Schizophr Res. 2024;266:190-196.
    PubMed         Abstract available

  15. CABUK T, Sevim N, Mutlu E, Yagcioglu AEA, et al
    Natural language processing for defining linguistic features in schizophrenia: A sample from Turkish speakers.
    Schizophr Res. 2024;266:183-189.
    PubMed         Abstract available

  16. ZHAO W, Cannon TD
    Moral learning and positive schizotypy: Social cognitive mechanisms in psychosis- proneness.
    Schizophr Res. 2024;266:156-164.
    PubMed         Abstract available

  17. BAKER SC, Messer SJ, Girgis RR, Horga G, et al
    Prior overweighting relates to delusional ideation in individuals at clinical high-risk for psychosis.
    Schizophr Res. 2024;266:153-155.
    PubMed        

  18. TIBIRICA L, Kohn J, Patapoff M, Williams AP, et al
    Acculturation and clinical symptoms of schizophrenia among Latine adults in the United States.
    Schizophr Res. 2024;266:145-152.
    PubMed         Abstract available

  19. PENG Z, Li Q, Liu X, Zhang H, et al
    A new schizophrenia screening instrument based on evaluating the patient's writing.
    Schizophr Res. 2024;266:127-135.
    PubMed         Abstract available

  20. MAKIPELTO V, Tuulio-Henriksson A, Hakulinen C, Niemela S, et al
    Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophrenia.
    Schizophr Res. 2024;266:118-126.
    PubMed         Abstract available

  21. BALLERINI M, Magnani F, Amorosi S, Dell'Anna C, et al
    Anomalous Self-Experiences are predictive of social dysfunction in people with schizophrenia.
    Schizophr Res. 2024;266:116-117.
    PubMed        

  22. TORREGROSSA LJ, Liu J, Armstrong K, Heckers S, et al
    Interplay between childhood trauma, bodily self-disturbances, and clinical phenomena in schizophrenia spectrum disorders: A network analysis.
    Schizophr Res. 2024;266:107-115.
    PubMed         Abstract available

  23. PERALTA V, de Jalon EG, Moreno-Izco L, Peralta D, et al
    The effect of anticholinergic burden of psychiatric medications on major outcome domains of psychotic disorders: A 21-year prospective cohort study.
    Schizophr Res. 2024;264:386-393.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.